The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a ...